These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4520646)

  • 1. [Chromosome aberrations in busulphan therapy (author's transl)].
    Gebhart E; Schwanitz G; Hartwich G
    Dtsch Med Wochenschr; 1974 Jan; 99(2):52-56. PubMed ID: 4520646
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chromosome changes in myleran therapy].
    Gebhardt E; Schwanitz G; Hartwich H
    Verh Dtsch Ges Inn Med; 1973; 79():1389-91. PubMed ID: 4524449
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myelocytic leukemia: cytogenetic consideration].
    Abe T
    Rinsho Ketsueki; 1975 Sep; 16(9):839-49. PubMed ID: 129583
    [No Abstract]   [Full Text] [Related]  

  • 4. [New chromosome abnormality in chronic myeloid leukemia].
    Berger R; Gyger M; Bussel
    Nouv Rev Fr Hematol (1978); 1976; 16(3):309-20. PubMed ID: 1070709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
    Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M
    Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
    Finney R; McDonald GA; Baikie AG; Douglas AS
    Br J Haematol; 1972 Sep; 23(3):283-8. PubMed ID: 4507535
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic sialadenitis. A toxic effect of prolonged busulfan therapy for chronic myelogenous leukaemia (author's transl)].
    Morales Polanco MR; Butron L; Echegoyen G; Pizzuto Chavez J
    Sangre (Barc); 1977; 22(2):243-51. PubMed ID: 266289
    [No Abstract]   [Full Text] [Related]  

  • 8. New approaches to the therapy of chronic granulocytic leukemia.
    Spiers AS
    Ser Haematol; 1975; 8(4):157-73. PubMed ID: 798284
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperlymphocytosis in a case of busulfan-induced medullar aplasia in chronic myeloid leukemia. Chromosome and functional study].
    Negrini AC; Azzolini A; Bertocchi I; Dolcino G
    Pathologica; 1967; 59(879):407-10. PubMed ID: 5273096
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy of chronic granulocytic leukemia.
    Crosby WH
    Arch Intern Med; 1977 Dec; 137(12):1717-8. PubMed ID: 270965
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of busulfan-induced pancytopenia.
    Stuart JJ; Crocker DL; Roberts HR
    Arch Intern Med; 1976 Oct; 136(10):1181-3. PubMed ID: 1067785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome changes in patients treated with "Myleran".
    Krajincanić B; Lazarov A; Zunić Z; Radojicić B
    Strahlentherapie; 1976 May; 151(5):459-62. PubMed ID: 1064182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dysplastic changes of the cervical epithelium caused by busulfan (myleran) (author's transl)].
    Juch E; Lauterbach A
    Geburtshilfe Frauenheilkd; 1982 Jan; 42(1):43-4. PubMed ID: 6949850
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytogenetic anomalies in a child born to a mother receiving busulfan for chronic myeloid leukaemia.
    Bhisey AN; Advani SH; Khare AG
    Indian J Cancer; 1982; 19(5):272-6. PubMed ID: 6219940
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of sister chromatid exchanges and chromosomal aberrations by busulfan in Philadelphia chromosome-positive chronic myeloid leukemia and normal bone marrow.
    Becher R; Prescher G
    Cancer Res; 1988 Jun; 48(12):3435-9. PubMed ID: 3163516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission induction in chronic granulocytic leukaemia using intermittent high-dose busulphan.
    Douglas ID; Wiltshaw E
    Br J Haematol; 1978 Sep; 40(1):59-64. PubMed ID: 280361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-five year survival of chronic granulocytic leukaemia with spontaneous karyotype conversion.
    Singer CR; McDonald GA; Douglas AS
    Br J Haematol; 1984 Jun; 57(2):309-13. PubMed ID: 6587904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
    Sánchez Fayos J; Outeiriño J; de Villalobos E; Valera M; Alonso M; Calabuig MT; Paniagua G
    Sangre (Barc); 1981; 26(1):65-71. PubMed ID: 6942520
    [No Abstract]   [Full Text] [Related]  

  • 19. [Undesired side-effects of busulfan].
    Japp H
    Dtsch Med Wochenschr; 1974 Dec; 99(51):2614-5. PubMed ID: 4530768
    [No Abstract]   [Full Text] [Related]  

  • 20. [Degenerative retinal conditions after treatment with Busulfan during pregnancy (author's transl)].
    Saraux H; Lefrancois A
    Klin Monbl Augenheilkd; 1977 Jun; 170(6):818-20. PubMed ID: 268448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.